Spots Global Cancer Trial Database for solid tumor malignancies
Every month we try and update this database with for solid tumor malignancies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT | NCT03435952 | Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... Malignant Neopl... | Pembrolizumab Clostridium Nov... Doxycycline | 18 Years - | M.D. Anderson Cancer Center | |
| A Phase 1 Study of AB521 in Renal Cell Carcinoma and Other Solid Tumors | NCT05536141 | Clear Cell Rena... Solid Tumors | AB521 | 18 Years - | Arcus Biosciences, Inc. | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| Autologous TLPO Vaccine Basket | NCT06175221 | Tumor, Solid Tumor Metastasi... Cancer Tumor | Tumor lysate, p... | 18 Years - | Elios Therapeutics, LLC | |
| A Study of CDX-585 in Patients With Advanced Malignancies | NCT05788484 | Non-small Cell ... Gastric Cancer Head and Neck C... Ovarian Cancer Primary Periton... Fallopian Tube ... Bladder Urothel... Colorectal Canc... Esophageal Canc... Hepatic Cancer Renal Cell Carc... Cholangiocarcin... Pancreatic Canc... Other Solid Tum... | CDX-585 | 18 Years - | Celldex Therapeutics | |
| Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors | NCT04669899 | Cancer | JTX-8064 pimivalimab | 18 Years - | Jounce Therapeutics, Inc. | |
| A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies | NCT01290380 | Solid Tumor Mal... | ASA404, DMXAA, ... | 18 Years - | Novartis | |
| Study of JTX-8064, as Monotherapy and in Combination With a PD-1 Inhibitor, in Adult Subjects With Advanced Refractory Solid Tumors | NCT04669899 | Cancer | JTX-8064 pimivalimab | 18 Years - | Jounce Therapeutics, Inc. | |
| Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies | NCT01110226 | Non-Small Cell ... Platinum Respon... | KML-001 Cisplatin | 18 Years - | University of Maryland, Baltimore | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| A Study of NPX887 for Participants With Solid Tumors Known to Express HHLA2/B7-H7 | NCT06240728 | Metastatic Mali... | NPX887 | 18 Years - | NextPoint Therapeutics, Inc. | |
| Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors | NCT01987726 | Recurrent Breas... Recurrent Colon... Recurrent Recta... Stage IV Breast... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... | cytology specim... laboratory biom... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies | NCT00761696 | Neoplasms | IPI-926 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies | NCT05085548 | Advanced Pancre... Solid Tumor Mal... | ProAgio Dose Le... ProAgio Dose Le... ProAgio Dose Le... | 18 Years - | ProDa BioTech, LLC | |
| A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies | NCT01290380 | Solid Tumor Mal... | ASA404, DMXAA, ... | 18 Years - | Novartis | |
| A Study of CDX-585 in Patients With Advanced Malignancies | NCT05788484 | Non-small Cell ... Gastric Cancer Head and Neck C... Ovarian Cancer Primary Periton... Fallopian Tube ... Bladder Urothel... Colorectal Canc... Esophageal Canc... Hepatic Cancer Renal Cell Carc... Cholangiocarcin... Pancreatic Canc... Other Solid Tum... | CDX-585 | 18 Years - | Celldex Therapeutics | |
| Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01118819 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies | NCT00195156 | Solid Tumor Mal... | ATRA-IV Depakote | 21 Years - | Weill Medical College of Cornell University | |
| A Phase 1 Study of AB521 in Renal Cell Carcinoma and Other Solid Tumors | NCT05536141 | Clear Cell Rena... Solid Tumors | AB521 | 18 Years - | Arcus Biosciences, Inc. | |
| A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies | NCT00761696 | Neoplasms | IPI-926 | 18 Years - | Infinity Pharmaceuticals, Inc. | |
| Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies | NCT03790488 | Cancer | JTX-4014 | 18 Years - | Jounce Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
